The function of CD56 and CD16 on iNKT cells is unknown [13] however, altered expression of these markers on NK cell phenotypes is often shown in CFS/ME patients [3, 5, 6, 10, 21, 22]. This evidence concerns the gene NCAM1 and myalgic encephalomeyelitis/chronic fatigue syndrome.